Over the past two decades, there has been progress in identifying various cellular mechanisms contributing to AD pathogenesis, but at present the underlying cause is unknown and thus far therapeutic strategies targeting Aβ and tau pathways have failed2,3. Here, MAPT is linked to Alzheimer disease.